AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $550,000 | +106.0% | 15,977 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $267,000 | -18.8% | 15,977 | -29.9% | 0.00% | 0.0% |
| Q1 2020 | $329,000 | -55.2% | 22,805 | +3.9% | 0.00% | -50.0% |
| Q4 2019 | $734,000 | +87.2% | 21,942 | +17.2% | 0.00% | +100.0% |
| Q3 2019 | $392,000 | +0.5% | 18,717 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $390,000 | -3.0% | 18,717 | +4.1% | 0.00% | 0.0% |
| Q1 2019 | $402,000 | -6.5% | 17,985 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $430,000 | -6.9% | 17,985 | +6.2% | 0.00% | 0.0% |
| Q3 2018 | $462,000 | +1.5% | 16,932 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $455,000 | -9.4% | 16,932 | +7.3% | 0.00% | 0.0% |
| Q1 2018 | $502,000 | -15.9% | 15,781 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $597,000 | +52.7% | 15,781 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $391,000 | +20.7% | 15,781 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $324,000 | +24.1% | 15,781 | +31.2% | 0.00% | 0.0% |
| Q1 2017 | $261,000 | +6.1% | 12,024 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $246,000 | +36.7% | 12,024 | 0.0% | 0.00% | – |
| Q3 2016 | $180,000 | +38.5% | 12,024 | 0.0% | 0.00% | – |
| Q2 2016 | $130,000 | – | 12,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |